Peer Review reports
From: Predicting responsiveness to GLP-1 pathway drugs using real-world data
Original Submission | ||
---|---|---|
29 Jun 2023 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
18 Jul 2023 | Author responded | Author comments - Maureen Gannon |
Resubmission - Version 3 | ||
18 Jul 2023 | Submitted | Manuscript version 3 |
5 Jan 2024 | Reviewed | Reviewer Report |
14 Feb 2024 | Reviewed | Reviewer Report - Reza Norouzirad |
6 Mar 2024 | Author responded | Author comments - Maureen Gannon |
Resubmission - Version 4 | ||
6 Mar 2024 | Submitted | Manuscript version 4 |
8 Mar 2024 | Author responded | Author comments - Maureen Gannon |
Resubmission - Version 5 | ||
8 Mar 2024 | Submitted | Manuscript version 5 |
11 Mar 2024 | Author responded | Author comments - Maureen Gannon |
Resubmission - Version 6 | ||
11 Mar 2024 | Submitted | Manuscript version 6 |
16 Aug 2024 | Author responded | Author comments - Maureen Gannon |
Resubmission - Version 7 | ||
16 Aug 2024 | Submitted | Manuscript version 7 |
28 Aug 2024 | Author responded | Author comments - Maureen Gannon |
Resubmission - Version 8 | ||
28 Aug 2024 | Submitted | Manuscript version 8 |
7 Sep 2024 | Reviewed | Reviewer Report - Reza Norouzirad |
19 Nov 2024 | Author responded | Author comments - Maureen Gannon |
Resubmission - Version 9 | ||
19 Nov 2024 | Submitted | Manuscript version 9 |
24 Nov 2024 | Reviewed | Reviewer Report - Reza Norouzirad |
Resubmission - Version 10 | ||
Submitted | Manuscript version 10 | |
Publishing | ||
2 Dec 2024 | Editorially accepted | |
18 Dec 2024 | Article published | 10.1186/s12902-024-01798-9 |
You can find further information about peer review here.